Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -25,469 | -24,698 | -22,106 | -10,348 | -26,754 |
| Depreciation Amortization | 632 | 367 | 208 | 166 | 570 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | -164 |
| Accounts receivable | -4,055 | N/A | N/A | N/A | 12,511 |
| Accounts payable and accrued liabilities | 1,257 | N/A | N/A | N/A | 764 |
| Other Working Capital | -32,121 | -18,827 | -6,749 | -5,918 | 21,893 |
| Other Operating Activity | 7,289 | 4,665 | 2,806 | 992 | -9,886 |
| Operating Cash Flow | $-52,467 | $-38,493 | $-25,841 | $-15,108 | $-1,066 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2,462 | -1,286 | -1,054 | -121 | -1,698 |
| Purchase Of Investment | -59,317 | -48,762 | -26,997 | -8,037 | -117,582 |
| Sale Of Investment | 71,617 | 61,767 | 35,647 | 2,842 | 110,405 |
| Investing Cash Flow | $9,838 | $11,719 | $7,596 | $-5,316 | $-8,875 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 32,166 | 501 | 280 | N/A | 48,511 |
| Financing Cash Flow | $32,166 | $501 | $280 | $N/A | $48,511 |
| Exchange Rate Effect | -2,144 | -2,526 | -2,001 | -2,349 | -1,581 |
| Beginning Cash Position | 74,867 | 74,867 | 74,867 | 74,867 | 37,878 |
| End Cash Position | 62,260 | 46,068 | 54,901 | 52,094 | 74,867 |
| Net Cash Flow | $-12,607 | $-28,799 | $-19,966 | $-22,773 | $36,989 |
| Free Cash Flow | |||||
| Operating Cash Flow | -52,467 | -38,493 | -25,841 | -15,108 | -1,066 |
| Capital Expenditure | -2,462 | -1,286 | -1,054 | -121 | -1,698 |
| Free Cash Flow | -54,929 | -39,779 | -26,895 | -15,229 | -2,764 |